TY - JOUR
T1 - Ovariectomy enhances renal cortical expression and function of cyclooxygenase-2
AU - Tada, Yuko
AU - Ichihara, Atsuhiro
AU - Koura, Yukako
AU - Okada, Hirokazu
AU - Kaneshiro, Yuki
AU - Hayashi, Matsuhiko
AU - Saruta, Takao
N1 - Funding Information:
This work was supported in part by a grant from the Ministry of Education, Science and Culture of Japan (15790439). We thank Ms. Rika Wakita for her dedicated attention to the many details involved in the preparation of this paper.
PY - 2004/11
Y1 - 2004/11
N2 - Background. Cyclooxygenase-2 (COX-2) inhibitors are used as analgesics in postmenopausal women, who develop edema and require a salt-restricted diet. This study was performed to determine the renal expression of COX-2 and on COX-2-dependent regulation of renal blood flow (RBF) in ovariectomized rats. Methods. Sprague-Dawley rats were divided into 4 groups: sham-operated rats fed a normal-salt diet (Sh+NS) or a low-salt diet (Sh+LS), and bilaterally ovariectomized rats fed a normal-salt diet (Ox+NS) or a low-salt diet (Ox+LS) (N = 6 in each group). Estrogen replacement therapy was performed on other ovariectomized rats. A renal clearance study was performed in anesthetized animals. Results. Ovariectomy increased renal cortical COX-2 expression independently of dietary salt intake (Sh+NS <Ox+N; Sh+LS <Ox+LS). Inhibition of COX-2 by NS398 reduced the urinary excretion of 6-keto-prostaglandin F1α in all 4 groups, although the reduction was greater in the Ox+LS group than in the Ox+NS and Sh+LS groups, which in turn had a greater reduction than the Sh+NS group. RBF significantly decreased in every group except the Sh+NS group, but no effect on blood pressure, inulin clearance, or urinary sodium excretion was seen. The decrease in RBF was significantly greater in the Ox+LS group than in the Sh+LS and Ox+NS group. The decrease in RBF was dependent on cortical RBF in the Sh+LS and Ox+NS groups, and on both cortical and medullary RBF in the Ox+LS group. Estrogen replacement therapy reversed the ovariectomy-induced changes. Conclusion. Estrogen-dependent COX-2 expression plays an important role in the RBF regulation in female rats.
AB - Background. Cyclooxygenase-2 (COX-2) inhibitors are used as analgesics in postmenopausal women, who develop edema and require a salt-restricted diet. This study was performed to determine the renal expression of COX-2 and on COX-2-dependent regulation of renal blood flow (RBF) in ovariectomized rats. Methods. Sprague-Dawley rats were divided into 4 groups: sham-operated rats fed a normal-salt diet (Sh+NS) or a low-salt diet (Sh+LS), and bilaterally ovariectomized rats fed a normal-salt diet (Ox+NS) or a low-salt diet (Ox+LS) (N = 6 in each group). Estrogen replacement therapy was performed on other ovariectomized rats. A renal clearance study was performed in anesthetized animals. Results. Ovariectomy increased renal cortical COX-2 expression independently of dietary salt intake (Sh+NS <Ox+N; Sh+LS <Ox+LS). Inhibition of COX-2 by NS398 reduced the urinary excretion of 6-keto-prostaglandin F1α in all 4 groups, although the reduction was greater in the Ox+LS group than in the Ox+NS and Sh+LS groups, which in turn had a greater reduction than the Sh+NS group. RBF significantly decreased in every group except the Sh+NS group, but no effect on blood pressure, inulin clearance, or urinary sodium excretion was seen. The decrease in RBF was significantly greater in the Ox+LS group than in the Sh+LS and Ox+NS group. The decrease in RBF was dependent on cortical RBF in the Sh+LS and Ox+NS groups, and on both cortical and medullary RBF in the Ox+LS group. Estrogen replacement therapy reversed the ovariectomy-induced changes. Conclusion. Estrogen-dependent COX-2 expression plays an important role in the RBF regulation in female rats.
KW - Cells of the thick ascending limb of Henle
KW - Cyclooxygenase-2
KW - Estrogen replacement therapy
KW - Ovariectomy
KW - Prostaglandins
KW - Renal plasma flow
UR - http://www.scopus.com/inward/record.url?scp=21644475328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21644475328&partnerID=8YFLogxK
U2 - 10.1111/j.1523-1755.2004.00983.x
DO - 10.1111/j.1523-1755.2004.00983.x
M3 - Article
C2 - 15496168
AN - SCOPUS:21644475328
SN - 0085-2538
VL - 66
SP - 1966
EP - 1976
JO - Kidney international
JF - Kidney international
IS - 5
ER -